Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

August 31, 2017

Conditions

Prostate or Bladder Cancer

Interventions

DRUG

1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

at the end of surgery

Trial Locations (1)

Ghent University Hospital, Ghent